Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Aravantinos G, Fountzilas G, Kosmidis P, Dimopoulos MA, Stathopoulos GP, Pavlidis N, Bafaloukos D, Papadimitriou C, Karpathios S, Georgoulias V, Papakostas P, Kalofonos HP, Grimani E, Skarlos DV; Hellenic Cooperative Oncology Group. Aravantinos G, et al. Among authors: bafaloukos d. Ann Oncol. 2005 Jul;16(7):1116-22. doi: 10.1093/annonc/mdi223. Epub 2005 May 31. Ann Oncol. 2005. PMID: 15928071 Free article. Clinical Trial.
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study.
Pavlidis N, Kosmidis P, Skarlos D, Briassoulis E, Beer M, Theoharis D, Bafaloukos D, Maraveyas A, Fountzilas G. Pavlidis N, et al. Among authors: bafaloukos d. Ann Oncol. 1992 Sep;3(8):631-4. doi: 10.1093/oxfordjournals.annonc.a058290. Ann Oncol. 1992. PMID: 1450045 Free article. Clinical Trial.
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV, Aravantinos G, Kosmidis P, Athanassiadis A, Stathopoulos GP, Pavlidis N, Bafaloukos D, Karphathios S, Papakostas P, Bamia C, Fountzilas G. Skarlos DV, et al. Among authors: bafaloukos d. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-57-S15-61. Semin Oncol. 1997. PMID: 9346224 Clinical Trial.
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group.
Fountzilas G, Athanassiadis A, Kalogera-Fountzila A, Aravantinos G, Bafaloukos D, Briasoulis E, Dombros N, Ioannidis I, Pavlidis N, Kosmidis P, Skarlos D. Fountzilas G, et al. Among authors: bafaloukos d. Eur J Cancer. 1997 Oct;33(11):1893-5. doi: 10.1016/s0959-8049(97)00217-7. Eur J Cancer. 1997. PMID: 9470853 Clinical Trial.
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.
Fountzilas G, Athanassiades A, Giannakakis T, Briasoulis E, Bafaloukos D, Kalogera-Fountzila A, Onienaoum A, Kalofonos H, Pectasides D, Andreopoulou E, Bamia C, Kosmidis P, Pavlidis N, Skarlos D. Fountzilas G, et al. Among authors: bafaloukos d. Ann Oncol. 1997 Dec;8(12):1213-20. doi: 10.1023/a:1008270307264. Ann Oncol. 1997. PMID: 9496386 Free article. Clinical Trial.
Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.
Fountzilas G, Athanassiades A, Papadimitriou V, Dimopoulos MA, Bafaloukos D, Aravantinos G, Nicolaides C, Kalofonos H, Papakostas P, Xiros N, Razi E. Fountzilas G, et al. Among authors: bafaloukos d. Oncology (Williston Park). 1998 Jan;12(1 Suppl 1):45-8. Oncology (Williston Park). 1998. PMID: 9516604 Free article.
196 results